2seventy bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
2seventy bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • 2seventy bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $181M, a 41.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $181M +$52.7M +41.2% Dec 31, 2023 10-K 2024-03-07
Q4 2022 $128M +$69.7M +120% Dec 31, 2022 10-K 2024-03-07
Q4 2021 $58.3M -$189M -76.5% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $247M Dec 31, 2020 10-K 2022-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.